Rani Therapeutics Announces New Preclinical Data Supporting Transenteric Delivery Of GLP-1 Incretin Triagonist With Rapid Weight Loss And Bioavailability Comparable To Injection

Benzinga · 10/17 12:05

Highlights Potential Of RaniPill Platform For Oral Obesity Treatments, With Phase 1 Study For RT-114 Expected In 2025